# A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated

> **NCT06148948** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1584862
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06148948
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-25
- **Primary completion:** 2024-05-21
- **Final completion:** 2024-05-21
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148948, "A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06148948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*